Trine Folseraas

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis
  2024 L1 58/100

1 assessed by us (0 reproduced) · 141 not yet assessed — every PubMed paper on record, linked below.

• Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses ↗

  Hepatology · 2026 · PMID 41627892
  not yet assessed
• Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation ↗

  Journal of Hepatology · 2026 · PMID 41722732
  not yet assessed
• OS-006-YI Development of a multi-biomarker model to predict transplant-free survival in primary sclerosing cholangitis: a multicenter retrospective study ↗

  Journal of Hepatology · 2026
  not yet assessed
• 23 - CHOLANGIOCARCINOMA IN INDIVIDUALS WITH CHRONIC LIVER DISEASE IS DIAGNOSED EARLIER LEADING TO BETTER PROGNOSIS ↗

  Gastroenterología y Hepatología · 2026
  not yet assessed
• SERUM METABOLOMIC PROFILING IDENTIFIES MARKERS OF CIRRHOSIS IN PRIMARY SCLEROSING CHOLANGITIS ↗

  Gastroenterología y Hepatología · 2026
  not yet assessed
• NOVEL BLOOD METABOLOMIC TESTS FOR THE DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS AND ASSOCIATED CHOLANGIOCARCINOMA ↗

  Gastroenterología y Hepatología · 2026
  not yet assessed
• Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis ↗

  Journal of Hepatology · 2026 · PMID 42002000
  not yet assessed
• Intrahepatic T cell analysis reveals Th17 and MAIT17 enrichment in primary sclerosing cholangitis ↗

  JHEP Reports · 2026 · PMID 42002038
  not yet assessed
• Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma ↗

  JHEP Reports · 2026 · PMID 42067191
  not yet assessed
• THU-385 Cholangiocarcinoma in individuals with chronic liver diseaseis diagnosed earlier leading to better prognosis ↗

  Journal of Hepatology · 2026
  not yet assessed
• THU-409 Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis by DNA methylation biomarkers in bile and plasma ↗

  Journal of Hepatology · 2026
  not yet assessed
• FRI-289 Indoles are colon-dependent circulating microbial metabolites associated with prognosis in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2026
  not yet assessed
• SAT-257-YI Serum metabolomic signatures for cirrhosis detection and prediction in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2026
  not yet assessed
• SAT-410 PRO-C3 shows prognostic and trial-endpoint potential in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2026
  not yet assessed
• SAT-249 Plasma C4 as a potential biomarker of cholangiocarcinoma in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2026
  not yet assessed
• GS-002 The microbe-derived metabolite imidazole propionate promotes the pathogenesis of primary sclerosing cholangitis via p38–mTORC1 signaling ↗

  Journal of Hepatology · 2026
  not yet assessed
• FRI-509 Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation ↗

  Journal of Hepatology · 2026
  not yet assessed
• 167 - CHOLANGIOCARCINOMA IN INDIVIDUALS WITH CHRONIC LIVER DISEASE IS DIAGNOSED EARLIER LEADING TO BETTER PROGNOSIS: EVIDENCE FROM THE INTERNATIONAL BTC REGISTRY ↗

  Gastroenterología y Hepatología · 2026
  not yet assessed
• 168 - NOVEL BLOOD METABOLOMIC TESTS FOR THE DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS AND ASSOCIATED CHOLANGIOCARCINOMA ↗

  Gastroenterología y Hepatología · 2026
  not yet assessed
• Current issues in clinical staging of perihilar cholangiocarcinoma—a European snapshot survey ↗

  Updates in Surgery · 2026 · PMID 42334804
  not yet assessed
• 27Novel blood metabolomic tests for the diagnosis of Primary Sclerosing Cholangitis and associated Cholangiocarcinoma ↗

  The Oncologist · 2026
  not yet assessed
• 1Developing a blood-based test for diagnosis, prognosis, and monitoring of cholangiocarcinoma ↗

  The Oncologist · 2026
  not yet assessed
• Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty ↗

  Figshare · 2026
  not yet assessed
• Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty ↗

  Figshare · 2026
  not yet assessed
• Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty ↗

  Scandinavian Journal of Gastroenterology · 2026 · PMID 42549941
  not yet assessed
• Cholangiocarcinoma 2026: status quo, unmet needs and priorities ↗

  Nature Reviews Gastroenterology & Hepatology · 2025 · PMID 41372578
  not yet assessed
• T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis ↗

  Nature Medicine · 2025 · PMID 40500415
  not yet assessed
• Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis ↗

  Hepatology · 2025 · PMID 40112296
  not yet assessed
• Liver transplantation for locally advanced non-resectable intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: early results from the TESLA trial ↗

  British journal of surgery · 2025 · PMID 40099404
  not yet assessed
• Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2025 · PMID 40846184
  not yet assessed
• Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study ↗

  Hepatology · 2025 · PMID 40238209
  not yet assessed
• Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC ↗

  JHEP Reports · 2025 · PMID 41757378
  not yet assessed
• Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis ↗

  Scandinavian Journal of Gastroenterology · 2025 · PMID 39764583
  not yet assessed
• A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits ↗

  JHEP Reports · 2025 · PMID 41321929
  not yet assessed
• GS-007-YI Novel “3-in-1” blood metabolomic test for the early diagnosis and risk stratification of primary sclerosing cholangitis and cholangiocarcinoma ↗

  Journal of Hepatology · 2025
  not yet assessed
• Cell type specific decoding of TGF-β2 production, signaling and outcome in the dynamics of cholestatic liver disease ↗

  Zeitschrift für Gastroenterologie · 2025
  not yet assessed
• FRI-313 Epstein-Barr virus is targeted by converging T and B cell responses in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2025
  not yet assessed
• TOP-347-YI Low vitamin B6 status associates with cholangiocarcinoma in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2025
  not yet assessed
• THU-048 Cell-type specific roles of TGF-β2 signaling in cholestatic liver disease progression and therapeutic targeting ↗

  Journal of Hepatology · 2025
  not yet assessed
• OS-056 Integrative spatial proteomics and transcriptomics of patient liver tissues unravel Claudin-1 as a mediator and therapeutic target for primary sclerosing cholangitis ↗

  Journal of Hepatology · 2025
  not yet assessed
• Mo1557: EPSTEIN-BARR VIRUS IS TARGETED BY CONVERGING T AND B CELL RESPONSES IN PRIMARY SCLEROSING CHOLANGITIS ↗

  Gastroenterology · 2025
  not yet assessed
• CHOLANGIOCARCINOMA IN INDIVIDUALS WITH CHRONIC LIVER DISEASE IS DIAGNOSED EARLIER, LEADING TO BETTER PROGNOSIS ↗

  Annals of Hepatology · 2025
  not yet assessed
• 87P Clinical characteristics and outcomes of patients with cholangiocarcinoma (CCA) undergoing liver transplantation (LT): An observational study from the ENSCCA registry ↗

  Annals of Oncology · 2025
  not yet assessed
• Reply: Competing risk and surveillance thresholds for HCC in patients with PSC ↗

  Hepatology · 2025 · PMID 41405465
  not yet assessed
• Cholangiocarcinoma 2026: status quo, unmet needs and priorities ↗

  2025
  not yet assessed
• Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease ↗

  Annals of Surgical Oncology · 2024 · PMID 38896226
  not yet assessed
• Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis ↗

  Hepatology Communications · 2024 · PMID 38967597
  not yet assessed
• Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis

  Cell Reports Medicine · 2024 · PMID 38901430
  L1 58/100
• OS-076-YI Bile extracellular vesicles hold protein biomarkers for the early diagnosis of cholangiocarcinoma in individuals with primary sclerosing cholangitis ↗

  Journal of Hepatology · 2024
  not yet assessed
• DOP14 Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international study ↗

  Journal of Crohn s and Colitis · 2024
  not yet assessed
• OS-023-YI Liver transplantation due to biliary tract dysplasia in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2024
  not yet assessed
• SAT-050 Liver transplantation for biliary tract cancer in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2024
  not yet assessed
• ASO Visual Abstract: Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease ↗

  Annals of Surgical Oncology · 2024 · PMID 38995450
  not yet assessed
• Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma ↗

  Journal of Hepatology · 2023 · PMID 36868481
  not yet assessed
• A second update on mapping the human genetic architecture of COVID-19 ↗

  Nature · 2023 · PMID 37674002
  not yet assessed
• A critical spotlight on the paradigms of FFPE-DNA sequencing ↗

  Nucleic Acids Research · 2023 · PMID 37351572
  not yet assessed
• Osteopontin characterizes bile duct–associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis ↗

  Hepatology · 2023 · PMID 37535809
  not yet assessed
• Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis ↗

  Nature Communications · 2023 · PMID 36828809
  not yet assessed
• ERCP for the initial management of malignant biliary obstruction – real world data on 596 procedures ↗

  Scandinavian Journal of Gastroenterology · 2023 · PMID 37994406
  not yet assessed
• Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis ↗

  Exposome · 2023 · PMID 36687160
  not yet assessed
• Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis ↗

  JHEP Reports · 2023 · PMID 38304234
  not yet assessed
• Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation ↗

  Journal of Hepatology · 2023 · PMID 37328069
  not yet assessed
• Primær skleroserende kolangitt ↗

  Tidsskrift for Den norske legeforening · 2023 · PMID 37987062
  not yet assessed
• ERCP for the initial management of malignant biliary obstruction – real world data on 596 procedures ↗

  Endoscopy · 2023
  not yet assessed
• LIQUID BIOPSY PROTEINS AS PSC-SPECIFIC AND PAN-CCA BIOMARKERS OF CANCER RISK, EARLY DIAGNOSIS AND SURVIVAL MIRRORING TUMOR CELLS ↗

  Gastroenterología y Hepatología · 2023
  not yet assessed
• Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis ↗

  Journal of Hepatology · 2023
  not yet assessed
• Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells ↗

  Journal of Hepatology · 2023
  not yet assessed
• Biopsy helpful in diagnosing a liver mass in pregnancy: focal nodular hyperplasia ↗

  The Lancet · 2023 · PMID 37633669
  not yet assessed
• Delineating signals of TGF-β2 expression induction and consequences of its signalling in cholestatic liver disease-mediated cholangiopathies ↗

  Zeitschrift für Gastroenterologie · 2023
  not yet assessed
• ERCP for the initial management of malignant biliary obstruction – real world data on 596 procedures ↗

  Figshare · 2023
  not yet assessed
• Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry ↗

  Journal of Hepatology · 2022 · PMID 35167909
  not yet assessed
• Detailed stratified GWAS analysis for severe COVID-19 in four European populations ↗

  Human Molecular Genetics · 2022 · PMID 35848942
  not yet assessed
• Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis ↗

  Hepatology · 2022 · PMID 35278227
  not yet assessed
• Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease ↗

  Communications Biology · 2022 · PMID 35058554
  not yet assessed
• Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry ↗

  Cancers · 2022 · PMID 35625993
  not yet assessed
• Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study ↗

  United European Gastroenterology Journal · 2022 · PMID 35107865
  not yet assessed
• Survey uncovering variations in the management of primary sclerosing cholangitis across Europe ↗

  JHEP Reports · 2022 · PMID 36164416
  not yet assessed
• Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis ↗

  European Radiology Experimental · 2022 · PMID 36396865
  not yet assessed
• Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry ↗

  Journal of Hepatology · 2022
  not yet assessed
• P302 Malignancy surveillance in patients with primary sclerosing cholangitis and Inflammatory Bowel Disease – keeping up with international guidelines? A Norwegian cohort study ↗

  Journal of Crohn s and Colitis · 2022
  not yet assessed
• Circulating vesicles hold etiology-related protein biomarkers of cholangiocarcinoma risk, early diagnosis and prognosis mirroring tumour cells ↗

  Journal of Hepatology · 2022
  not yet assessed
• Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Resected Perihilar Cholangiocarcinoma, the ENS-CCA Registry ↗

  HPB · 2022
  not yet assessed
• Mapping the human genetic architecture of COVID-19 ↗

  Nature · 2021 · PMID 34237774
  not yet assessed
• Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile ↗

  Hepatology · 2021 · PMID 34435693
  not yet assessed
• Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF ↗

  JHEP Reports · 2021 · PMID 34485881
  not yet assessed
• Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies ↗

  Scientific Reports · 2021 · PMID 34017024
  not yet assessed
• Associations of neopterin and kynurenine–tryptophan ratio with survival in primary sclerosing cholangitis ↗

  Scandinavian Journal of Gastroenterology · 2021 · PMID 33583308
  not yet assessed
• Diagnostikk og behandling av autoimmun hepatitt ↗

  Tidsskrift for Den norske legeforening · 2021 · PMID 34182737
  not yet assessed
• Detailed stratified GWAS analysis for severe COVID-19 in four European populations ↗

  medRxiv · 2021
  not yet assessed
• REPLY: ↗

  Hepatology · 2021 · PMID 33550618
  not yet assessed
• REPLY: ↗

  Hepatology · 2021 · PMID 33998692
  not yet assessed
• Abstract 841: Risk of hepatobiliary & pancreatic cancer in inflammatory bowel disease ↗

  Cancer Research · 2021
  not yet assessed
• Cross-tissue transcriptome-wide association studies of 885,176 individuals and seven diseases of the gut-brain axis identify susceptibility genes shared between schizophrenia and inflammatory bowel disease ↗

  Research Square · 2021
  not yet assessed
• Presentation, Management and Outcome of Cholangiocarcinoma in Europe: Results From Real-World Patient Registry ↗

  SSRN Electronic Journal · 2021
  not yet assessed
• Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation ↗

  Hepatology · 2020 · PMID 33226645
  not yet assessed
• Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System ↗

  Hepatology · 2020 · PMID 33073396
  not yet assessed
• Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities ↗

  Hepatology · 2020 · PMID 31925805
  not yet assessed
• Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers ↗

  JHEP Reports · 2020 · PMID 32939446
  not yet assessed
• Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities ↗

  Zeitschrift für Gastroenterologie · 2020
  not yet assessed
• The <i>ABO</i> blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis ↗

  medRxiv · 2020
  not yet assessed
• Enhanced liver fibrosis test and liver stiffness variation over time in a prospective cohort of primary sclerosing cholangitis patients ↗

  Journal of Hepatology · 2020
  not yet assessed
• Novel protein biomarkers in serum extracellular vesicles for the diagnosis of cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis (PSC) ↗

  Journal of Hepatology · 2020
  not yet assessed
• Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis ↗

  Liver International · 2019 · PMID 31216595
  not yet assessed
• Liver metastases (LM) from intrahepatic cholangiocarcinoma (iCCA): Outcomes from the European Network for the study of cholangiocarcinoma (ENS-CCA) registry and implications on current American Joint Committee on Cancer (AJCC) staging ↗

  Annals of Oncology · 2019
  not yet assessed
• THU-006-Aberrant DNA methylation in bile accurately detects cholangiocarcinoma in patients with primary sclerosing cholangitis ↗

  Journal of Hepatology · 2019
  not yet assessed
• Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis ↗

  Hepatology · 2018 · PMID 30102768
  not yet assessed
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report ↗

  World Journal of Surgical Oncology · 2018 · PMID 30185175
  not yet assessed
• Peribiliary glands and biliary tree stem cells are involved in the pathogenesis of cholangiocarcinoma arising in patients affected by primary sclerosing cholangitis ↗

  Journal of Hepatology · 2018
  not yet assessed
• PO-091 Droplet digital PCR based detection of aberrantly methylated genes in bile identifies cholangiocarcinoma in patients with primary sclerosing cholangitis ↗

  ESMO Open · 2018
  not yet assessed
• Impact of Geographical Region on Death or Transplantation and on Malignancy in Primary Sclerosing Cholangitis - a Multicenter Retrospective Study of the International PSC Study Group (IPSCSG)

  Data Archiving and Networked Services (DANS) · 2018
  not yet assessed
• Primary sclerosing cholangitis – a comprehensive review ↗

  Journal of Hepatology · 2017 · PMID 28802875
  not yet assessed
• Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma ↗

  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2017 · PMID 28844951
  not yet assessed
• Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis ↗

  American Journal Of Pathology · 2017 · PMID 29248458
  not yet assessed
• Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis ↗

  Gut · 2017 · PMID 28779025
  not yet assessed
• <scp>HLA</scp> haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry ↗

  HLA · 2017 · PMID 28695657
  not yet assessed
• Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis ↗

  2017
  not yet assessed
• 原発性硬化性胆管炎のゲノムワイド関連研究を行い,新たなリスク座位を同定し,炎症性腸疾患との遺伝的類似性を数値化した

  Nature Genetics · 2017
  not yet assessed
• Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis ↗

  Italian Journal of Anatomy and Embryology · 2017
  not yet assessed
• Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) ↗

  Nature Reviews Gastroenterology & Hepatology · 2016 · PMID 27095655
  not yet assessed
• Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci ↗

  Nature Genetics · 2016 · PMID 26974007
  not yet assessed
• Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease ↗

  Nature Genetics · 2016 · PMID 27992413
  not yet assessed
• Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

  Open MIND · 2016
  not yet assessed
• Genotype-Phenotype Analysis across 130,422 Genetic Variants Identifies Rspo3 as the First Genome-Wide Significant Modifier Gene in Primary Sclerosing Cholangitis ↗

  Journal of Hepatology · 2016
  not yet assessed
• Novel Therapeutic Targets for Primary Sclerosing Cholangitis-Associated Biliary Tract Cancer Identified by Tissue Sequencing ↗

  Journal of Hepatology · 2016
  not yet assessed
• Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

  QUT ePrints (Queensland University of Technology) · 2016
  not yet assessed
• Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells ↗

  Nature Communications · 2015 · PMID 25891430
  not yet assessed
• Cancer Risk and Surveillance in Primary Sclerosing Cholangitis ↗

  Clinics in Liver Disease · 2015 · PMID 26593292
  not yet assessed
• A common genetic variant of <i>fucosyltransferase 2</i> correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis ↗

  United European Gastroenterology Journal · 2015 · PMID 26966527
  not yet assessed
• A common FUT2 variant correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis ↗

  Zeitschrift für Gastroenterologie · 2015
  not yet assessed
• <i>Fut2</i> genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis ↗

  Alimentary Pharmacology & Therapeutics · 2014 · PMID 24612312
  not yet assessed
• Genetics in PSC: What Do the “Risk Genes” Teach Us? ↗

  Clinical Reviews in Allergy & Immunology · 2014 · PMID 24736995
  not yet assessed
• Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis ↗

  Nature Genetics · 2013 · PMID 23603763
  not yet assessed
• FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis ↗

  Journal of Hepatology · 2013 · PMID 23958938
  not yet assessed
• Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. ↗

  University of Maribor digital library (University of Maribor) · 2013
  not yet assessed
• Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci ↗

  Journal of Hepatology · 2012 · PMID 22521342
  not yet assessed
• Genome-Wide Association Analysis in Primary Sclerosing Cholangitis And Ulcerative Colitis Identifies Risk Loci at Gpr35 And Tcf4 ↗

  Hepatology · 2012 · PMID 22821403
  not yet assessed
• FUT2 and FUT3 depending cut-off values in PSC-patients increase diagnostic accuracy of CA19–9 for detection of biliary malignancies ↗

  Zeitschrift für Gastroenterologie · 2012
  not yet assessed
• Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9 ↗

  Hepatology · 2011 · PMID 21425313
  not yet assessed
• Genetics in primary sclerosing cholangitis ↗

  Best Practice & Research Clinical Gastroenterology · 2011 · PMID 22117637
  not yet assessed
• To MMP or not to MMP: a role for matrix metalloproteinase 3 in primary sclerosing cholangitis? ↗

  Liver International · 2011 · PMID 21645205
  not yet assessed
• 102 NOVEL SUSCEPTIBILITY LOCI FOR PRIMARY SCLEROSING CHOLANGITIS IDENTIFIED BY GENOME-WIDE ASSOCIATION AND REPLICATION ANALYSIS ↗

  Journal of Hepatology · 2011
  not yet assessed
• Novel Susceptibility Loci for Primary Sclerosing Cholangitis Identified by Genome-Wide Association and Replication Analysis ↗

  Gastroenterology · 2011
  not yet assessed